Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 3
2004 6
2005 7
2006 4
2007 1
2008 8
2009 5
2010 4
2011 9
2012 12
2013 8
2014 10
2015 8
2016 10
2017 8
2018 7
2019 6
2020 8
2021 9
2022 8
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
Domínguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gröschel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR Jr, Lange C; TBnet and RESIST-TB networks. Domínguez J, et al. Among authors: van leth f. Lancet Infect Dis. 2023 Apr;23(4):e122-e137. doi: 10.1016/S1473-3099(22)00875-1. Epub 2023 Feb 28. Lancet Infect Dis. 2023. PMID: 36868253 Review.
Management of patients with multidrug-resistant tuberculosis.
Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K. Lange C, et al. Among authors: van leth f. Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622. Int J Tuberc Lung Dis. 2019. PMID: 31315696 Review.
Relative cost of multidrug-resistant TB medicines in Europe.
Günther G, Guglielmetti L, Leu C, van Leth F, Lange C. Günther G, et al. Among authors: van leth f. Int J Tuberc Lung Dis. 2023 May 1;27(5):341-344. doi: 10.5588/ijtld.23.0026. Int J Tuberc Lung Dis. 2023. PMID: 37143231 No abstract available.
Testing for LTBI: more of the same or a step forward?
van Leth F, Sester M. van Leth F, et al. Int J Tuberc Lung Dis. 2018 Jun 1;22(6):591. doi: 10.5588/ijtld.18.0267. Int J Tuberc Lung Dis. 2018. PMID: 29862938 No abstract available.
Availability and costs of medicines for the treatment of tuberculosis in Europe.
Günther G, Guglielmetti L, Leu C, Lange C, van Leth F; Tuberculosis Network European Trials group. Günther G, et al. Among authors: van leth f. Clin Microbiol Infect. 2023 Jan;29(1):77-84. doi: 10.1016/j.cmi.2022.07.026. Epub 2022 Aug 10. Clin Microbiol Infect. 2023. PMID: 35961488 Free PMC article.
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
van Leth F, Brinkmann F, Cirillo DM, Dheda K, Duarte R, Guglielmetti L, Kuksa L, Lange C, Mitnick C, Skrahina A, Zaman K, Bothamley G. van Leth F, et al. Eur Respir J. 2019 Jan 3;53(1):1802089. doi: 10.1183/13993003.02089-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30606765 Free article. No abstract available.
143 results